{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:40Z","timestamp":1740147280149,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Rare and Intractable Diseases, Health and Labor Sciences Research"},{"name":"Pediatric Research from the Ministry of Health, Labour and Welfare"},{"name":"Grant-in-Aid from Japan Agency for Medical Research and Development"},{"name":"Scientific Re- search from the Ministry of Education, Culture, Sports, Science, and Technology"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glycogen storage disease (GSD) type Ia is a glycogenesis disorder with long-term complications such as hepatomegaly and renal dysfunction and is caused by congenital loss of glucose-6-phosphatase (G6Pase) expression. G6Pase is essential for the final step of gluconeogenesis and glycogenolysis, and its deficiency causes clinical hypoglycemia in the fasting state during infancy. Contrastingly, patients also show blood glucose trends and glucose intolerance similar to those in type II diabetes. Owing to the contrasting presentation of hypoglycemia with glucose intolerance, glucose control in patients remains a challenge, requiring management of both fasting hypoglycemia and post-prandial hyperglycemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The patient was a 45-year old Asian (Japanese) woman who showed disease onset at 3\u00a0years of age, when hypoglycemia and hepatomegaly were observed, and GDS type Ia was diagnosed by the lack of G6Pase activity. Over the past 45\u00a0years, she presented hyperglycemia and dumping syndrome like symptoms (a feeling of fullness, even after eating just a small amount, abdominal cramping, nausea, sweating, flushing, or light-headedness and rapid heartbeat) at 2\u00a0hours after food intake. Her liver and kidney dysfunction also worsened over time. Treatment with exercise combined with a sodium-glucose co-transporter 2 inhibitor and an alpha glucosidase inhibitor alleviated her glucose intolerance and dumping syndrome-like symptoms, without increasing hypoglycemic events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case suggests SGLT2 inhibitor as a promising candidate for treating glucose intolerance in GSD type Ia without worsening of hypoglycemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-020-02658-5","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:15:24Z","timestamp":1613578524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SGLT2 inhibition alleviated hyperglycemia, glucose intolerance, and dumping syndrome-like symptoms in a patient with glycogen storage disease type Ia: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Daisuke","family":"Katayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashige","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mitsubuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-0951","authenticated-orcid":false,"given":"Shirou","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"2658_CR1","doi-asserted-by":"publisher","first-page":"47098","DOI":"10.1074\/jbc.M309472200","volume":"278","author":"JJ Shieh","year":"2003","unstructured":"Shieh JJ, Pan CJ, Mansfield BC, Chou JY. A glucose-6-phosphate hydrase. Widely expressed outside the liver. Can explain age dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem. 2003;278:47098\u2013103.","journal-title":"J Biol Chem"},{"issue":"1","key":"2658_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13256-017-1462-5","volume":"11","author":"A Cohn","year":"2017","unstructured":"Cohn A, Ohri A. Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report. J Med Case Rep. 2017;11(1):319.","journal-title":"J Med Case Rep"},{"key":"2658_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0026-0495(81)90178-5","volume":"30","author":"RC Powell","year":"1981","unstructured":"Powell RC, Wentworth SM, Brandt IK. Endogenous glucose production in type I glycogen storage disease. Metabolism. 1981;30:443\u201350.","journal-title":"Metabolism"},{"key":"2658_CR4","first-page":"E513","volume":"247","author":"E Tsalikian","year":"1984","unstructured":"Tsalikian E, Simmons P, Gerich JE, Howard C, Haymond MW. Glucose production and utilization in children with glycogen storage disease type 1. Am J Physiol. 1984;247:E513\u20139.","journal-title":"Am J Physiol"},{"issue":"2","key":"2658_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01799686","volume":"13","author":"JE Collins","year":"1990","unstructured":"Collins JE, Bartlett K, Leonard JV, Aynsley-Green A. Glucose production rates in type 1 glycogen storage disease. J Inherit Metab Dis. 1990;13(2):195\u2013206.","journal-title":"J Inherit Metab Dis"},{"issue":"25","key":"2658_CR6","doi-asserted-by":"publisher","first-page":"26215","DOI":"10.1074\/jbc.M402036200","volume":"279","author":"JJ Shieh","year":"2004","unstructured":"Shieh JJ, Pan CJ, Mansfield BC, Chou JY. A potential new role for muscle in blood glucose homeostasis. J Biol Chem. 2004;279(25):26215\u20139.","journal-title":"J Biol Chem"},{"key":"2658_CR7","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/s00431-002-1007-8","volume":"161","author":"RH Bandsma","year":"2002","unstructured":"Bandsma RH, Smit GP, Kuipers F. Disturbed lipid metabolism in glycogen storage disease type 1. Eur J Pediatr. 2002;161:S65\u20139.","journal-title":"Eur J Pediatr"},{"key":"2658_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/liv.12912","volume":"36","author":"T Fukuda","year":"2016","unstructured":"Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. The impact of non-alcoholic fatty liver disease on incident type2 diabetes mellitus in non-overweight individuals. Liver Int. 2016;36:275\u201383.","journal-title":"Liver Int"},{"key":"2658_CR9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, B\u00f6hm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Duk\u00e1t A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sj\u00f6strand M, Langkilde AM, DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995\u20132008.","journal-title":"N Engl J Med"},{"issue":"15","key":"2658_CR10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sj\u00f6str\u00f6m CD, Toto RD, Langkilde AM, Wheeler DC, DAPA-CKD Trial Committees and Investigators. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436\u201346 (2020 Sep 24).","journal-title":"N Engl J Med"},{"key":"2658_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/hepr.13236","volume":"49","author":"Y Sumida","year":"2019","unstructured":"Sumida Y, Murotani K, Saito M, Tamasawa A, Osonoi Y, Yoneda M, Osonoi T. Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: a prospective, single-arm trial (LEAD trial). Hepatol Res. 2019;49:64\u201371.","journal-title":"Hepatol Res"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-020-02658-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:55:36Z","timestamp":1613580936000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2658"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02658-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained (reference No. 2160) from the Kumamoto University Research Ethical Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}